Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacomicrobiomics of venlafaxine treatment in depression
NL-OMON59066Phase 4Completed
- Sponsor
- Radboud University Medical Center
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of venlafaxine in major depressive disorder (MDD), sponsored by Radboud University Medical Center. Started Oct 2024; status: completed.
02
Drugs
venlafaxine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NL-OMON59066.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON59066.